Cullen Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249M Sell
2,073,354
-217,687
-10% -$25.1M 2.56% 8
2025
Q4
$241M Sell
2,291,041
-52,411
-2% -$4.92M 2.63% 7
2025
Q3
$197M Buy
2,343,452
+66,976
+3% +$5.52M 2.15% 17
2025
Q2
$180M Buy
2,276,476
+39,800
+2% +$3.16M 2.05% 19
2025
Q1
$201M Buy
2,236,676
+270,966
+14% +$25.3M 2.32% 18
2024
Q4
$196M Sell
1,965,710
-85,946
-4% -$8.86M 2.28% 17
2024
Q3
$233M Buy
2,051,656
+457,890
+29% +$54.4M 2.54% 13
2024
Q2
$197M Sell
1,593,766
-69,897
-4% -$9M 2.27% 15
2024
Q1
$220M Sell
1,663,663
-241,386
-13% -$29.8M 2.44% 15
2023
Q4
$208M Sell
1,905,049
-546,678
-22% -$56.7M 3.08% 2
2023
Q3
$252M Sell
2,451,727
-88,067
-3% -$9.49M 2.95% 5
2023
Q2
$293M Sell
2,539,794
-113,450
-4% -$12.9M 2.62% 2
2023
Q1
$282M Buy
2,653,244
+556,724
+27% +$60.1M 2.58% 3
2022
Q4
$233M Sell
2,096,520
-776,001
-27% -$79.3M 2.99% 2
2022
Q3
$247M Buy
2,872,521
+305,921
+12% +$27.3M 2.65% 4
2022
Q2
$234M Sell
2,566,600
-18,993
-0.7% -$1.68M 2.35% 7
2022
Q1
$212M Buy
2,585,593
+254,108
+11% +$20M 1.95% 19
2021
Q4
$179M Sell
2,331,485
-22,815
-1% -$1.82M 1.67% 27
2021
Q3
$177M Buy
2,354,300
+32,735
+1% +$2.49M 1.74% 25
2021
Q2
$181M Buy
2,321,565
+174,968
+8% +$13M 1.75% 24
2021
Q1
$158M Buy
2,146,597
+1,658,716
+340% +$122M 1.71% 25
2020
Q4
$38.1M Sell
487,881
-93,947
-16% -$7.19M 2.11% 18
2020
Q3
$46.1M Sell
581,828
-1,771
-0.3% -$139K 2.67% 10
2020
Q2
$43.1M Sell
583,599
-92,487
-14% -$6.96M 2.42% 20
2020
Q1
$49.6M Sell
676,086
-67,119
-9% -$5.28M 2.86% 10
2019
Q4
$64.5M Sell
743,205
-180,827
-20% -$14.9M 2.53% 16
2019
Q3
$74.2M Sell
924,032
-71,668
-7% -$5.74M 2.98% 3
2019
Q2
$79.7M Buy
995,700
+1,148
+0.1% +$87.9K 3.11% 1
2019
Q1
$78.9M Buy
994,552
+692
+0.1% +$51.8K 3.11% 3
2018
Q4
$72.5M Sell
993,860
-101,583
-9% -$7.17M 3.12% 5
2018
Q3
$74.2M Sell
1,095,443
-17,910
-2% -$1.14M 2.73% 6
2018
Q2
$64.5M Sell
1,113,353
-125,483
-10% -$7.08M 2.44% 15
2018
Q1
$64.4M Buy
1,238,836
+12,398
+1% +$670K 2.28% 19
2017
Q4
$65.9M Buy
1,226,438
+21,903
+2% +$1.21M 2.26% 22
2017
Q3
$73.6M Buy
1,204,535
+19,116
+2% +$1.16M 2.56% 17
2017
Q2
$72.5M Buy
1,185,419
+17,376
+1% +$1.06M 2.55% 15
2017
Q1
$70.8M Sell
1,168,043
-228,475
-16% -$13.9M 2.49% 17
2016
Q4
$78.4M Sell
1,396,518
-162,712
-10% -$9.52M 2.71% 14
2016
Q3
$92.9M Buy
1,559,230
+34,317
+2% +$2.01M 3.14% 6
2016
Q2
$83.8M Buy
1,524,913
+403
+0% +$21.4K 2.95% 12
2016
Q1
$77M Sell
1,524,510
-34,144
-2% -$1.67M 2.72% 16
2015
Q4
$78.6M Sell
1,558,654
-25,854
-2% -$1.3M 2.65% 16
2015
Q3
$74.7M Sell
1,584,508
-360,391
-19% -$19.1M 2.62% 16
2015
Q2
$106M Sell
1,944,899
-144,624
-7% -$8.11M 3.37% 2
2015
Q1
$115M Buy
2,089,523
+1,572
+0.1% +$89K 3.21% 1
2014
Q4
$113M Sell
2,087,951
-149,812
-7% -$8.35M 3.07% 7
2014
Q3
$127M Sell
2,237,763
-63
-0% -$3.54K 3.47% 2
2014
Q2
$124M Sell
2,237,826
-113,236
-5% -$6.18M 3.21% 5
2014
Q1
$127M Buy
2,351,062
+1,132
+0% +$58.6K 3.45% 1
2013
Q4
$112M Buy
2,349,930
+9,547
+0.4% +$436K 2.95% 7
2013
Q3
$106M Buy
2,340,383
+20,048
+0.9% +$915K 3.01% 5
2013
Q2
$103M Buy
+2,320,335
New +$104M 3.12% 4

Other funds holding MRK

Cullen Capital Management's MRK Position: Q1 2026 in Review

Cullen Capital Management reduced its Merck (MRK) stake by 9.5% in Q1 2026, selling an estimated $25.1M and leaving 2,073,354 shares worth $249M. The position accounts for 2.56% of the portfolio, ranked #8.

Cullen Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $293M in Q2 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cullen Capital Management held 2,073,354 shares of Merck worth $249M as of Q1 2026.
  • Cullen Capital Management sold 217,687 Merck shares in Q1 2026, an estimated $25.1M.
  • Merck made up 2.56% of Cullen Capital Management's portfolio in Q1 2026, its #8 holding.
  • Cullen Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Cullen Capital Management's Merck position peaked at $293M in Q2 2023.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cullen Capital Management's 13F filing for Q1 2026, filed 15 May 2026.